Abstract

The first two decades of the XXI century in the Far Eastern Federal District continue to be characterized by a constantly decreasing level of the population living on its territory with an annual increase in the number of patients with cancer pathology, which makes a negative contribution to the already negative demographic situation in the region. The purpose of this study was to make a scientific assessment of the main morbidity and mortality rates of the population from malignant tumors of the trachea, bronchi and lung in the Far Eastern Federal District over the past ten years (2008-2017). In the course of the work, morbidity and mortality indicators, reporting forms of statistical records of cancer patients and regulatory documents of higher organizations, information on ten-year observations of the dynamics of changes in the numerical values of indicators of the studied pathology were used. The main indicators of medical care for oncology patients in the Far Eastern Federal District are shown, and it was found out that 3180 new cases of tracheal, bronchial and lung malignant neoplasms were registered in 2017, which is 30.9% more than ten years ago (in 2008 there were 2429 cases). The maximum number of cases was in the age group of 50-69 years. The number of patients with stages I-II (29.4%) of the cancer process increased slightly whereas the number of patients with advanced forms of the disease increased significantly (41.5%). The percentage of patients identified during routine check-ups was 28.0% (in 2008 it was 15.8%). Mortality in the first year from the time of diagnosis was reduced to 49.2% (in 2008 – 55.0%) remaining, at the same time, at very high numbers, which makes it impossible to characterize medical care for oncology patients as adequate for the time required. In the structure of total mortality, trachea, bronchus and lung tumors (20.7%) take the first place significantly exceeding the Russian level (17.3%). There was designated the quality of the service’s activity according to the confidence index of accounting for this category of patients, which in 2017 did not fall below 0.6 in any of the territories forming the Far Eastern Federal District. A great deal of work of primary health care institutions responsible for identifying malignant neoplasms in the initial stages of the process, unfortunately, has not led to the desired reduction in morbidity and mortality in the Far Eastern Federal District in the last decade. On the contrary, the level of intensive indicators of medical care for cancer patients in the region remains high, with an annual increase in mortality and the number of cases, especially among the female population

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call